Evaluating Efgartigimod in Patients With Guillain-Barr é Syndrome
Condition: Guillain-Barre Syndrome Interventions: Drug: Efgartigimod Alfa-Fcab; Drug: Intravenous Immunoglobulin (IVIg) Sponsors: Chafic Karam; argenx Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Guillain-Barr Syndrome | Research